Prospective Validation of Gallium-68 PSMA-PET/CT in Primary Staging of Prostate Cancer Patients.
Prospective validation of gallium-68 (68Ga) prostate specific membrane antigen (PSMA)-PET/CT in initial staging of prostate cancer is lacking. This study evaluates diagnostic accuracy of 68Ga-PSMA-PET/CT in detection of lymph node metastases in patients with intermediate-high risk prostate cancer. From October 2017 to October 2018, newly diagnosed prostate cancer patients with negative bone scan and >10% […]